Newcastle disease virus suppress glycolysis pathway and induce breast cancer cells death
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2020-06-27 / Virusdisease 2020 Sep;31(3):341-348Combined wIRA-Hyperthermia and Hypofractionated Re-Irradiation in the Treatment of Locally Recurrent Breast Cancer: Evaluation of Therapeutic Outcome Based on a Novel Size Classification
/in Breast Cancer, Hyperthermia, International Publications /von 2020-03-06 / Cancers (Basel) 2020 Mar;12(3)Dendritic cell vaccine for the effective immunotherapy of breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2020-03-04 / Biomed. Pharmacother. 2020 Jun;126:110046Breast cancer stem cell RNA-pulsed dendritic cells enhance tumor cell killing by effector T cells
/in Breast Cancer, Dendritic Cells, International Publications /von 2020-01-23 / Oncol Lett 2020 Mar;19(3):2422-2430Efficacy of Combination Neoadjuvant Chemotherapy and Regional Inductive Moderate Hyperthermia in the Treatment of Patients With Locally Advanced Breast Cancer
/in Breast Cancer, Hyperthermia, International Publications /von 2020-01-01 / Technol Cancer Res Treat 2020 Jan-Dec;19:1533033820963599Evaluation of Newcastle disease virus mediated dendritic cell activation and cross-priming tumor-specific immune responses ex vivo
/in Breast Cancer, Dendritic Cells, International Publications, Newcastle Disease Virus /von 2019-11-01 / Int J Cancer 2020 01;146(2):531-541Evaluation of a Recombinant Newcastle Disease Virus Expressing Human IL12 against Human Breast Cancer
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2019-09-30 / Sci Rep 2019 Sep;9(1):139992-Deoxyglucose and Newcastle Disease Virus Synergize to Kill Breast Cancer Cells by Inhibition of Glycolysis Pathway Through Glyceraldehyde3-Phosphate Downregulation
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2019-09-27 / Front Mol Biosci 2019;6:90Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response
/in Breast Cancer, Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2019-08-14 / Front Immunol 2019;10:1939
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de